Those who are infected with COVID 19 should also take the vaccine. This is said by Krishna Biya, chairman and MD (CMD) of Bharat Biotech. He also said that India is well prepared in terms of logistics for distribution of the vaccine. Krishna Ila was speaking at a virtual session organized by industry organization CII. This session was on the subject of ‘Sero Surveillance Significance in Immunogenicity and Safety in Pre and Post Vaccination Era’.
CMD of Bharat Biotech said that people who are infected with corona should take the vaccine or not, the answer to this question is yes. This is because corona-infected patients may not have a good tea sales response.
Trials at 24 centers in the country
Talking about trials of Bharat Biotech’s COVID vaccine, he said that the company has conducted trials at 24 centers across the country for the vaccine to work. Tier 1, Tier 2 and Tier 3 cities were also covered to better identify the effectiveness of the vaccine. On the distribution of vaccine in India, Krishna Ila said that the country’s preparation is good for this and the Indian immunization system is very fast.